Cargando…
Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
BACKGROUND: Patients with coronary disease may have unknown diabetes or prediabetes. We evaluated 3‐year outcomes after percutaneous coronary intervention (PCI) with contemporary drug‐eluting stents (DES) in patients with silent diabetes, prediabetes, and normoglycemia. METHODS: All BIO‐RESORT trial...
Autores principales: | Ploumen, Eline H., Buiten, Rosaly A., Kok, Marlies M., Doggen, Carine J.M., van Houwelingen, K. Gert, Stoel, Martin G., de Man, Frits H.A.F., Hartmann, Marc, Zocca, Paolo, Linssen, Gerard C.M., Doelman, Cees, Kant, Gert D., von Birgelen, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496069/ https://www.ncbi.nlm.nih.gov/pubmed/31625262 http://dx.doi.org/10.1002/ccd.28536 |
Ejemplares similares
-
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020) -
Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials
por: Ploumen, Eline H., et al.
Publicado: (2021) -
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial
por: Ploumen, Eline H., et al.
Publicado: (2021) -
Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
por: Ploumen, Eline H., et al.
Publicado: (2022) -
Safety and efficacy outcomes of 3rd generation DES in an all‐comer population of patients undergoing PCI: 12‐month and 24‐month results of the e‐Biomatrix French registry
por: Maupas, Eric, et al.
Publicado: (2017)